Prescription Drugs
US Congress 115th Congress
Veteran Overmedication Prevention Act of 2017 [S.992]
[Veterans ]
[Healthcare ]
[Mental Health ]
[Overdose Prevention ]
[Public Health ]
[Pharmaceuticals ]
[Medicare and Medicaid ]
Veteran Overmedication Prevention Act of 2017 This bill requires the Department of Veterans Affairs (VA) to contract with the National Academies of Sciences, Engineering, and Medicine to review the deaths of all covered veterans who died by suicide during the last five years, regardless of whether information relating to such deaths has been reported by the Centers for Disease Control and Prevention. A "covered veteran" is any veteran who received VA hospital care or medical services during the five-year period preceding the veteran's death. The
(continued...)
Sponsored by: Sen. John McCain
Read Twice And Referred To The Committee On Veterans' Affairs. on 05/01/2017
Spread the world
Gettr US Congress 115th Congress
CREATES Act of 2017 Creating and Restoring Equal Access To Equivalent Samples Act of 2017 [HB-2212]
[Pharmaceuticals ]
[Consumer Protection ]
CREATES Act of 2017 Creating and Restoring Equal Access To Equivalent Samples Act of 2017
Sponsored by: Rep. Janice Schakowsky
Referred To The Subcommittee On Health. on 04/28/2017
Spread the world
US Congress 115th Congress
CREATES Act of 2018 Creating and Restoring Equal Access to Equivalent Samples Act of 2018 [S.974]
[Pharmaceuticals ]
[Consumer Protection ]
CREATES Act of 2018 Creating and Restoring Equal Access to Equivalent Samples Act of 2018
Sponsored by: Sen. Susan Collins
Committee On The Judiciary. Reported By Senator Grassley With An Amendment In The Nature Of A Substitute. Without Written Report. on 06/21/2018
Spread the world
US Congress 115th Congress
FDA Reauthorization Act of 2017 [S.934]
[Pharmaceuticals ]
[Healthcare ]
[Public Health ]
[Medicare and Medicaid ]
[Funding ]
[Budget and Spending ]
[Consumer Protection ]
FDA Reauthorization Act of 2017 TITLE I--FEES RELATING TO DRUGS Prescription Drug User Fee Amendments of 2017 (Sec. 102) This bill amends the Federal Food, Drug, and Cosmetic Act to extend through FY2022 and revise Food and Drug Administration (FDA) user fees for new drug applications. User fees are eliminated for supplements to new drug applications and drug manufacturing facilities. TITLE II--FEES RELATING TO DEVICES Medical Device User Fee Amendments of 2017 (Sec. 203) The bill extends through FY2022 and revises FDA user fees for medical devices.
(continued...)
Sponsored by: Sen. Lamar Alexander
Committee On Health, Education, Labor, And Pensions. Ordered To Be Reported With An Amendment In The Nature Of A Substitute Favorably. Markup Report Cq on 05/11/2017
Spread the world
US Congress 115th Congress
Speeding Access to Already Approved Pharmaceuticals Act of 2017 [HB-2113]
[Healthcare ]
[Pharmaceuticals ]
Speeding Access to Already Approved Pharmaceuticals Act of 2017 This bill amends the Federal Food, Drug, and Cosmetic Act to require the Food and Drug Administration to facilitate the development and expedite the review of a new drug, biological product, or medical device that has been approved in the European Union.
Sponsored by: Rep. Tim Ryan
Referred To The Subcommittee On Health. on 04/21/2017
Spread the world
US Congress 115th Congress
FAST Generics Act of 2017 Fair Access for Safe and Timely Generics Act of 2017 [HB-2051]
[Healthcare ]
[Pharmaceuticals ]
[Public Health ]
[Consumer Protection ]
FAST Generics Act of 2017 Fair Access for Safe and Timely Generics Act of 2017 This bill amends the Federal Food, Drug, and Cosmetic Act to prohibit the license holder of a Food and Drug Administration (FDA)-approved drug or biological product from restricting availability of the medication for testing by a product developer seeking to develop a drug, generic drug, or biosimilar, including restricting availability with a risk evaluation and mitigation strategy (REMS). Upon request, the license holder of a medication that is not subject to a REMS
(continued...)
Sponsored by: Rep. Janice Schakowsky
Referred To The Subcommittee On Health. on 04/07/2017
Spread the world
US Congress 115th Congress
Creating High-Quality Results and Outcomes Necessary to Improve Chronic (CHRONIC) Care Act of 2017 [S.870]
[Healthcare ]
[Medicare and Medicaid ]
[Public Health ]
[Senior Citizens ]
[Pharmaceuticals ]
[Technology and Innovation ]
[Science ]
Creating High-Quality Results and Outcomes Necessary to Improve Chronic (CHRONIC) Care Act of 2017 This bill amends title XVIII (Medicare) of the Social Security Act to: extend the Independence at Home demonstration program; modify provisions regarding access to home dialysis therapy under Medicare and special needs plans under Medicare Advantage (MA); expand testing of the MA Value-Based Insurance Design test model; allow an MA plan to provide additional telehealth benefits to enrollees and, to chronically ill enrollees, certain supplemental health
(continued...)
Sponsored by: Sen. Robert Casey
Committee On Finance. Reported By Senator Hatch With An Amendment In The Nature Of A Substitute. With Written Report No. 115-146. on 08/03/2017
Spread the world
US Congress 115th Congress
Opioid PACE Act of 2017 Opioid Preventing Abuse through Continuing Education Act of 2017 [HB-2063]
[Healthcare ]
[Public Health ]
[Overdose Prevention ]
[Pharmaceuticals ]
[Education ]
[Law Enforcement ]
[Criminal Justice ]
Opioid PACE Act of 2017 Opioid Preventing Abuse through Continuing Education Act of 2017 This bill amends the Controlled Substances Act to require a practitioner (other than a hospital, pharmacy, pharmacist, or veterinarian) to comply with a training requirement, as a condition of obtaining or renewing a registration to prescribe or dispense opioids for the treatment of pain or pain management.
Sponsored by: Rep. Sean Maloney
Referred To The Subcommittee On Crime, Terrorism, Homeland Security, And Investigations. on 05/01/2017
Spread the world
US Congress 115th Congress
Restoring the Patient's Voice Act of 2017 [HB-2077]
[Healthcare ]
[Insurance ]
[Pharmaceuticals ]
[Public Health ]
Restoring the Patient's Voice Act of 2017 This bill amends the Employee Retirement Income Security Act of 1974 (ERISA) to require a group health plan to establish an exception to medication step-therapy protocol in specified cases. A medication step-therapy protocol establishes a specific sequence in which prescription drugs are covered by a group health plan or a health insurance issuer. To warrant an exception to the protocol, at least one of the following circumstances must be met: (1) the treatment is contraindicated, (2) the treatment is expected
(continued...)
Sponsored by: Rep. Sean Maloney
Introduced In House on 04/06/2017
Spread the world
US Congress 115th Congress
Budgeting for Opioid Addiction Treatment Act [HB-2038]
[Budget and Spending ]
[Healthcare ]
[Taxes ]
[Pharmaceuticals ]
[Public Health ]
[Overdose Prevention ]
[Mental Health ]
[Funding ]
[Grants ]
Budgeting for Opioid Addiction Treatment Act This bill amends the Internal Revenue Code, with respect to excise taxes on manufacturers, to impose a one cent per milligram fee on the sale of active opioids by the manufacturer, producer, or importer. The fee excludes prescription drugs used exclusively for the treatment of opioid addiction as part of a medically assisted treatment effort. The Department of Health and Human Services (HHS) must establish a program to provide rebates or discounts to cancer and hospice patients to ensure that they do
(continued...)
Sponsored by: Rep. Earl Blumenauer
Referred To The Subcommittee On Health. on 04/07/2017
Spread the world
US Congress 115th Congress
Treat and Reduce Obesity Act of 2017 [S.830]
[Healthcare ]
[Medicare and Medicaid ]
[Public Health ]
[Pharmaceuticals ]
[Senior Citizens ]
Treat and Reduce Obesity Act of 2017 This bill allows coverage, under Medicare, of intensive behavioral therapy for obesity furnished by providers other than primary care physicians and practitioners. Additionally, it allows coverage under Medicare's prescription drug benefit of drugs used for the treatment of obesity or for weight loss management for individuals who are overweight.
Sponsored by: Sen. Chuck Grassley
Read Twice And Referred To The Committee On Finance. on 04/05/2017
Spread the world
US Congress 115th Congress
Ensuring Seniors Access to Local Pharmacies Act of 2017 [HB-1939]
[Healthcare ]
[Medicare and Medicaid ]
[Pharmaceuticals ]
[Senior Citizens ]
[Public Health ]
Ensuring Seniors Access to Local Pharmacies Act of 2017 This bill modifies requirements regarding access to preferred pharmacies (i.e., pharmacies that provide reduced enrollee cost sharing for prescription drugs) under a Medicare prescription drug plan (PDP). Specifically, if a Medicare PDP has, in its pharmacy network, one or more preferred pharmacies located in a health shortage or medically underserved area, then the PDP sponsor must allow any pharmacy in the health shortage or medically underserved area to join the preferred pharmacy network
(continued...)
Sponsored by: Rep. Barbara Comstock
Referred To The Subcommittee On Health. on 04/17/2017
Spread the world
US Congress 115th Congress
To amend part B of title XVIII of the Social Security Act to exclude customary prompt pay discounts from manufacturers to wholesalers from the average sales price for drugs and biologicals under Medicare, and for other purposes. [HB-1920]
[Medicare and Medicaid ]
[Pharmaceuticals ]
To amend part B of title XVIII of the Social Security Act to exclude customary prompt pay discounts from manufacturers to wholesalers from the average sales price for drugs and biologicals under Medicare, and for other purposes. This bill modifies the methodology used to calculate a manufacturer's average sales price for certain drugs covered under Medicare. Specifically, the bill excludes, from a manufacturer's average sales price calculation, customary prompt pay discounts extended to wholesalers.
Sponsored by: Rep. Patrick Meehan
Referred To The Subcommittee On Health. on 04/17/2017
Spread the world
US Congress 115th Congress
Treat and Reduce Obesity Act of 2017 [HB-1953]
[Healthcare ]
[Medicare and Medicaid ]
[Public Health ]
[Pharmaceuticals ]
[Senior Citizens ]
Treat and Reduce Obesity Act of 2017 This bill allows coverage, under Medicare, of intensive behavioral therapy for obesity furnished by providers other than primary care physicians and practitioners. Additionally, it allows coverage under Medicare's prescription drug benefit of drugs used for the treatment of obesity or for weight loss management for individuals who are overweight.
Sponsored by: Rep. Gerald Connolly
Referred To The Subcommittee On Health. on 04/17/2017
Spread the world
US Congress 115th Congress
Territories Medicare Prescription Drug Assistance Equity Act of 2017 [S.815]
[Healthcare ]
[Medicare and Medicaid ]
[Pharmaceuticals ]
Territories Medicare Prescription Drug Assistance Equity Act of 2017
Sponsored by: Sen. Richard Blumenthal
Read Twice And Referred To The Committee On Finance. on 04/04/2017
Spread the world
US Congress 115th Congress
Honoring Hometown Heroes Act [HB-1892]
[Defense ]
[Environmental ]
[Finance ]
[Agriculture ]
[Infrastructure ]
[Public Lands and National Parks ]
[Taxes ]
[Trade ]
[Transportation and Motor Vehicles ]
[Budget and Spending ]
[Small Business ]
[Insurance ]
[Disaster Relief ]
[Economic Development ]
[Energy ]
[Food ]
[Healthcare ]
[Housing ]
[Labor, Jobs, Employment ]
[Medicare and Medicaid ]
[Military ]
[Public Health ]
[Education ]
[Veterans ]
[Children and Youth ]
[Family-Related Legislation ]
[Human Services ]
[Pensions ]
[Senior Citizens ]
[Unemployment ]
Honoring Hometown Heroes Act DIVISION A--HONORING HOMETOWN HEROES ACT Honoring Hometown Heroes Act (Sec. 10102) This division authorizes the governor of a state, territory, or possession of the United States or the Mayor of the District of Columbia to proclaim that the U.S. flag shall be flown at half-staff in the event of the death of a first responder (public safety officer) working in such jurisdiction who dies while serving in the line of duty. DIVISION B--SUPPLEMENTAL APPROPRIATIONS, TAX RELIEF, AND MEDICAID CHANGES RELATING TO CERTAIN DISASTERS
(continued...)
Sponsored by: Rep. Ted Poe
Became Public Law No: 115-123. (txt | Pdf) on 02/09/2018
Spread the world
US Congress 115th Congress
Prescription Drug Monitoring Act of 2017 [HB-1854]
[Healthcare ]
[Pharmaceuticals ]
[Public Health ]
[Overdose Prevention ]
[Grants ]
[Funding ]
[Law Enforcement ]
Prescription Drug Monitoring Act of 2017 This bill requires a state that receives grant funds under the prescription drug monitoring program (PDMP) or the controlled substance monitoring program to comply with specified requirements, including a requirement to share its PDMP data with other states. The Department of Justice (DOJ) or Department of Health and Human Services may withhold grant funds from a state that fails to comply. To facilitate data sharing among states, the bill directs DOJ to award a grant under the Comprehensive Opioid Abuse
(continued...)
Sponsored by: Rep. Gerald Connolly
Referred To The Subcommittee On Crime, Terrorism, Homeland Security, And Investigations. on 04/24/2017
Spread the world
US Congress 115th Congress
Veteran Overmedication Prevention Act of 2017 [S.788]
[Healthcare ]
[Veterans ]
[Mental Health ]
[Overdose Prevention ]
[Medicare and Medicaid ]
[Public Health ]
Veteran Overmedication Prevention Act of 2017 This bill requires the Department of Veterans Affairs (VA) to contract with the National Academies of Sciences, Engineering, and Medicine (or another private, not-for-profit entity with comparable expertise) to review the deaths of all covered veterans who died by suicide during the last five years. A "covered veteran" is any veteran who received VA hospital care or medical services during the five-year period preceding the veteran's death. The review shall include: the total numbers of veterans who
(continued...)
Sponsored by: Sen. John McCain
Read Twice And Referred To The Committee On Veterans' Affairs. on 03/30/2017
Spread the world
US Congress 115th Congress
Prescription Drug Monitoring Act of 2017 [S.778]
[Healthcare ]
[Pharmaceuticals ]
[Public Health ]
[Overdose Prevention ]
[Funding ]
[Grants ]
[Law Enforcement ]
Prescription Drug Monitoring Act of 2017 This bill requires a state that receives grant funds under the prescription drug monitoring program (PDMP) or the controlled substance monitoring program to comply with specified requirements, including a requirement to share its PDMP data with other states. The Department of Justice (DOJ) or Department of Health and Human Services may withhold grant funds from a state that fails to comply. To facilitate data sharing among states, the bill directs DOJ to award a grant under the Comprehensive Opioid Abuse
(continued...)
Sponsored by: Sen. Angus King
Read Twice And Referred To The Committee On Health, Education, Labor, And Pensions. on 03/30/2017
Spread the world
US Congress 115th Congress
Student and Student Athlete Opioid Misuse Prevention Act [S.786]
[Healthcare ]
[Public Health ]
[Sports ]
[Education ]
[Mental Health ]
[Overdose Prevention ]
[Pharmaceuticals ]
[Children and Youth ]
Student and Student Athlete Opioid Misuse Prevention Act This bill amends the Public Health Service Act to authorize the Substance Abuse and Mental Health Services Administration (SAMHSA) to support programs for schools, athletic programs, or communities to prevent prescription drug misuse and addiction related to opioids and other medications for pain or injury recovery. SAMHSA must report annually on federal programs to prevent pain medication misuse and addiction.
Sponsored by: Sen. Joe Manchin
Read Twice And Referred To The Committee On Health, Education, Labor, And Pensions. on 03/30/2017